Sansure Biotech Inc. develops and sells upstream nucleic acid extraction kits, real time PCR diagnostic and research kits, and fluorescence systems in China and internationally. The company offers novel coronavirus nucleic acid diagnostic kits; viral hepatitis and AIDS, blood screening, and extraction kits; cancer-related biomarkers; and kits for respiratory tract diseases, STDs, digestive tract diseases, prenatal and postnatal care, and genetic diseases, as well as instruments and other consumables. It serves hospitals and laboratories. The company was founded in 2008 and is based in Changsha, China.

Mr. Zhongping  Deng

Deputy General Manager

Mr. Haixiao  Wang

Mr. Lizhong  Dai

Chairman of the Board & GM

Mr. Liu  Kai

Mr. Peng  Zhu

Chief Financial Officer, Deputy GM, Board Secretary & Director

Ms. Jun  Zhou

Mr. Jian  Zhu

Mr. Jia  Liu

Deputy GM & Director

Mr. Xialin  Yu

Mr. Xu  Fan

Pavadinimas	Rinkos kapitalizacija
ConvaTec Group Plc	0M
Jiangsu Apon Medical Technology Co., Ltd.	0M
Bausch + Lomb Corporation	0M
SD BioSensor, Inc	0M
Ypsomed Holding AG	0M
InfuSystem Holdings, Inc.	0M
Menicon Co., Ltd.	0M
Alcon Inc.	0M
Nipro Corporation	0M
OrbusNeich Medical Group Holdings Limited	0M

Sansure Biotech Inc.

Sansure Biotech Inc. Konkurentų sąrašas

Pagrindiniai konkurentai